Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-PCSK9 Monoclonal Antibody market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-PCSK9 Monoclonal Antibodymarket, defines the market attractiveness level of Anti-PCSK9 Monoclonal Antibody market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-PCSK9 Monoclonal Antibody industry, describes the types of Anti-PCSK9 Monoclonal Antibody market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-PCSK9 Monoclonal Antibody market and the development prospects and opportunities of Anti-PCSK9 Monoclonal Antibody industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-PCSK9 Monoclonal Antibody market in Chapter 13.
By Player:
Sanofi + Regeneron
Amgen
By Type:
Alizumab
Evolocumab
By End-User:
Hypercholesterolemia
Atherosclerotic Cardiovascular Disease
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-PCSK9 Monoclonal Antibody Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-PCSK9 Monoclonal Antibody Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-PCSK9 Monoclonal Antibody Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-PCSK9 Monoclonal Antibody Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-PCSK9 Monoclonal Antibody Market Analysis and Outlook to 2022
-
7.1 Global Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
-
7.2 United States Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
-
7.3 Europe Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
-
7.4 China Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
-
7.5 Japan Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
-
7.6 India Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
-
7.7 South Korea Anti-PCSK9 Monoclonal Antibody Consumption (2017-2022)
8 Region and Country-wise Anti-PCSK9 Monoclonal Antibody Market Analysis and Outlook to 2028
-
8.1 Global Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.2 United States Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.3 Europe Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.4 China Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.5 Japan Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.6 India Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-PCSK9 Monoclonal Antibody Consumption Forecast (2022-2028)
9 Global Anti-PCSK9 Monoclonal Antibody Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Alizumab Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Evolocumab Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypercholesterolemia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Atherosclerotic Cardiovascular Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Anti-PCSK9 Monoclonal Antibody Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Alizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Evolocumab Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypercholesterolemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Atherosclerotic Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-PCSK9 Monoclonal Antibody Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-PCSK9 Monoclonal Antibody Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-PCSK9 Monoclonal Antibody Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-PCSK9 Monoclonal Antibody Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-PCSK9 Monoclonal Antibody Market Competitive Analysis
-
14.1 Sanofi + Regeneron
-
14.1.1 Sanofi + Regeneron Company Details
-
14.1.2 Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Anti-PCSK9 Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Anti-PCSK9 Monoclonal Antibody Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-PCSK9 Monoclonal Antibody
-
Figure Anti-PCSK9 Monoclonal Antibody Picture
-
Table Global Anti-PCSK9 Monoclonal Antibody Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-PCSK9 Monoclonal Antibody Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-PCSK9 Monoclonal Antibody Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-PCSK9 Monoclonal Antibody Consumption by Country (2017-2022)
-
Figure United States Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure China Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure India Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-PCSK9 Monoclonal Antibody Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-PCSK9 Monoclonal Antibody Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-PCSK9 Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Evolocumab Consumption and Growth Rate (2017-2022)
-
Figure Global Hypercholesterolemia Consumption and Growth Rate (2017-2022)
-
Figure Global Atherosclerotic Cardiovascular Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Alizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Evolocumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypercholesterolemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Atherosclerotic Cardiovascular Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-PCSK9 Monoclonal Antibody Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-PCSK9 Monoclonal Antibody Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi + Regeneron (Foundation Year, Company Profile and etc.)
-
Table Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi + Regeneron Anti-PCSK9 Monoclonal Antibody Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Anti-PCSK9 Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Anti-PCSK9 Monoclonal Antibody Product and Service
-
